Opko Health
OPK
235 hedge funds and large institutions have $290M invested in Opko Health in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 66 increasing their positions, 59 reducing their positions, and 29 closing their positions.
21% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 29
12% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 59
2.18% more ownership
Funds ownership: 26.77% → 28.95% (+2.2%)
4% more capital invested
Capital invested by funds: $279M → $290M (+$10.9M)
0% more funds holding
Funds holding: 234 → 235 (+1)
45% less call options, than puts
Call options by funds: $9.74M | Put options by funds: $17.7M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.08M |
| 2 |
Jane Street
New York
|
+$3.48M |
| 3 |
Millennium Management
New York
|
+$3.23M |
| 4 |
Morgan Stanley
New York
|
+$2.81M |
| 5 |
Lazard Asset Management
New York
|
+$2.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$6.84M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
-$1.25M |
| 3 |
Charles Schwab
San Francisco,
California
|
-$1.09M |
| 4 |
CC
Clearline Capital
New York
|
-$1.08M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$970K |
OPK Hedge Fund Activity: Q4 2024 in Review
235 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q4 2024, worth a combined $290M — up 3.9% from $279M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new OPK positions and 29 closed out — a net gain of 6 holders — while 66 added to existing stakes and 59 trimmed.
The largest buyer was UBS Group, adding an estimated $6.08M. The largest seller was Invesco, cutting an estimated $6.84M.
- 235 institutional investors held Opko Health (OPK) as of Q4 2024, up from 234 in Q3 2024.
- Funds reported $290M of Opko Health stock for Q4 2024, up 3.9% quarter-over-quarter.
- 35 funds opened new Opko Health positions in Q4 2024 and 29 closed out, a net change of +6 holders.
- The largest Opko Health buyer in Q4 2024 was UBS Group, an estimated $6.08M added.
- The largest Opko Health seller in Q4 2024 was Invesco, an estimated $6.84M sold.
Based on aggregated 13F filings for Q4 2024.